-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
West Pharmaceutical Services Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- West Pharmaceutical Services Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $21.9M, a 37.1% decline year-over-year.
- West Pharmaceutical Services Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $102M, a 5.11% decline year-over-year.
- West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2023 was $122M, a 6.63% increase from 2022.
- West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2022 was $115M, a 7% increase from 2021.
- West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2021 was $107M, a 47.9% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)